glp-1 blood clot Glucagon‐Like Peptide‐1 Receptor Agonists and Risk of Venous Thromboembolism: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials GLP-1 Therapies May Benefit MPN

Science 385 , 258260 (2024)

In fact, liraglutide (1.8 mg daily) and semaglutide (0.5 mg weekly) both significantly outperformed dulaglutide (1.5 mg weekly) for weight loss in head-to-head trials at doses that induce comparable HbA1c lowering (13, 22)

Glucose Imbalances or Low Blood Glucose This side effect is more common in people with type 2 diabetes, mainly when semaglutide is used with insulin or other glucose-lowering medications

The time it takes for semaglutide GLP-1 to reduce hunger can vary between individuals, but significant appetite suppression typically becomes noticeable after 1 to 2 weeks of consistent use

Nutrients 16 , 3593 (2024)